1. Grem JL. 5-Fluorinated pyrimidines. In Cancer Chemotherapy and Biotherapy. Principles and Practice. Chabner BA and Longo DL (eds.), Lippincott-Raven, Philadelphia, 1996, pp. 149–210.
2. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res., 55 (1995) 1687–1690.
3. Glazer RI and Lloyd LS. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol. Pharmacol., 21 (1982) 468–473.
4. Kanamaru R, Kakuta H, Sato T, Ishioka C, and Wakui A. The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro. Cancer Chemother. Pharmacol., 17 (1986) 43–46.
5. Will CL and Dolnick BJ. 5-Fluorouracil inhibits dihydrofolate reductase precursor mRNA processing and/or nuclear mRNA stability in methotrexate-resistant KB cells. J. Biol. Chem.,264 (1989) 21,413–21,421.